West Pharmaceutical
692 hedge funds and large institutions have $24B invested in West Pharmaceutical in 2023 Q1 according to their latest regulatory filings, with 126 funds opening new positions, 246 increasing their positions, 217 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
13% more repeat investments, than reductions
Existing positions increased: 246 | Existing positions reduced: 217
9% more funds holding
Funds holding: 634 → 692 (+58)
0.34% more ownership
Funds ownership: 93.34% → 93.67% (+0.34%)
Holders
692
Holding in Top 10
11
Calls
$60.1M
Puts
$24.1M
Top Buyers
| 1 | +$325M | |
| 2 | +$188M | |
| 3 | +$188M | |
| 4 |
JP Morgan Chase
New York
|
+$124M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$78.8M |
Top Sellers
| 1 | -$171M | |
| 2 | -$112M | |
| 3 | -$90.3M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$72.7M |
| 5 |
Renaissance Technologies
New York
|
-$69.4M |